1-3 of 3
Eunice S. Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia

Dimitrios Papaioannou, Deedra Nicolet, Hatice G. Ozer, Krzysztof Mrózek, Stefano Volinia, Paolo Fadda, Andrew J. Carroll, Jessica Kohlschmidt, Jonathan E. Kolitz, Eunice S. Wang, Richard M. Stone, John C. Byrd, Ramiro Garzon, Clara D. Bloomfield
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (8): 1451–1459.
https://doi.org/10.1158/1535-7163.MCT-18-1125
Published: 01 August 2019
View article titled, Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia
Open the PDF for Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

IMGN779, a Novel CD33-Targeting Antibody–Drug Conjugate with DNA-Alkylating Activity, Exhibits Potent Antitumor Activity in Models of AML

Yelena Kovtun, Paul Noordhuis, Kathleen R. Whiteman, Krystal Watkins, Gregory E. Jones, Lauren Harvey, Katharine C. Lai, Scott Portwood, Sharlene Adams, Callum M. Sloss, Gerrit Jan Schuurhuis, Gert Ossenkoppele, Eunice S. Wang, Jan Pinkas
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2018) 17 (6): 1271–1279.
https://doi.org/10.1158/1535-7163.MCT-17-1077
Published: 31 May 2018
View article titled, IMGN779, a Novel CD33-Targeting Antibody–Drug Conjugate with DNA-Alkylating Activity, Exhibits Potent Antitumor Activity in Models of AML
Open the PDF for IMGN779, a Novel CD33-Targeting Antibody–Drug Conjugate with DNA-Alkylating Activity, Exhibits Potent Antitumor Activity in Models of AML in another window
Journal Articles

Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy In vivo in Human Acute Myeloid Leukemia Models

Deepika Lal, Jennifer A. Park, Kellie Demock, Joseph Marinaro, Amanda M. Perez, Mei-Hui Lin, Lili Tian, Terry J. Mashtare, Michael Murphy, Joshua Prey, Meir Wetzler, Gerald J. Fetterly, Eunice S. Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (10): 2737–2751.
https://doi.org/10.1158/1535-7163.MCT-10-0334
Published: 10 October 2010
View article titled, Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy <em>In vivo</em> in Human Acute Myeloid Leukemia Models
Open the PDF for Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy <em>In vivo</em> in Human Acute Myeloid Leukemia Models in another window
Includes: Supplementary data